IMPORTANT CORONAVIRUS UPDATE
In accordance with Chancellor Moloney’s announcement that UMass Lowell will scale back and minimize its on-campus presence for Fall 2020, the university will shift immediately to a modified Stage 3 research re-entry plan, referred to below as Stage 3B.
The original plan for Stage 4 was to move towards an almost fully open program in the fall. This shift is a recognition that maintaining low density for safety will be a longer term requirement due to ongoing COVID-19 concerns. Hence, beyond our prior focus on urgent tasks, we wish to now support continuation of regular research activities, while maintaining low floor and building densities. Where reasonable, we also seek to limit opening entire buildings and floors if alternative functional locations can be identified that help to preserve staff and energy resources.
For Stage 3B, campus access continues to be restricted, but limited access will be permitted with advance approval and in compliance with requirements issued by the research re-entry committee and university for safety and other matters. Scheduling of lab or studio access days and times for each individual will, however, be done locally rather than by the committee.
Please note Stage 3B is an updated version of the Stage 3 plan with the following modifications and/or reminders:
For those who wish to apply for re-entry or make modifications to their currently approved plan for Stage 3B, please use the online Long Term Access for Research / Scholarship application.
We are pleased to work with everyone to continue the positive momentum of the research enterprise while maintaining strict attention to the health practices that keep our community safe. If you have any further questions, please refer to our Frequently Asked Questions (FAQ) page or email: VCRI@uml.edu.
The University of Massachusetts Lowell Office of Technology Commercialization (OTC) supports the commercialization of inventions emerging from research conducted at UMass Lowell. OTC provides researchers with the support to analyze and achieve the full potential of their inventions and to develop a commercialization plan for each technology. Innovative technologies from UMass Lowell are licensed to all types of companies, ranging from enterprising start-ups to large multinational corporations. OTC-generated revenues help to sustain the University's mission of scientific research and economic development.